Breaking Bev Craig Elected Mayor of Greater Manchester Prosecutors Seek Dismissal of Vandalism Case Against David Hearn Over Reflecting Pool Incident Zelenskyy Seeks Trump’s Help With Musk for Starlink Use in Russia Turkish Man Arrested in UK on U.S. Charges Related to Hamas Funding Allegations FCC Chairman Defends Agency Actions Amidst ABC Dispute
Friday July 31, 2026
75° St. Louis, MO Cloudy
Become a Contributor
Section

Partners

Securities Fraud Investigation Into Capricor Therapeutics, Inc. (CAPR) Continues Following Critical FDA Review Ahead of Advisory Committee Meeting – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
Press Release

Securities Fraud Investigation Into Capricor Therapeutics, Inc. (CAPR) Continues Following Critical FDA Review Ahead of Advisory Committee Meeting – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

LOS ANGELES, July 30, 2026 (GLOBE NEWSWIRE) — The Law Offices of Frank R. Cruz announces an investigation of Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NASDAQ: CAPR)…

The Law Offices of Frank R. Cruz · 9 minutes ago
Read Full Story